Amphetamine: effects on catecholamine systems and behavior.
paper
Cited
Public
Unavailable
- Authors
- Seiden, L S; Sabol, K E; Ricaurte, G A
- Year
- 1993
- Journal
- Annual review of pharmacology and toxicology
- PMID
- 8494354
- DOI
- 10.1146/annurev.pa.33.040193.003231
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Deep Proteome Profiling of Rat Dorsal Striatal Synaptoneurosomes Following Methamphetamine Exposure. | Rodriguez LG et al. | β | 2026 | β |
| Pathogenic mechanism underlying parkinsonism induced by neurotoxicants (MPTP and 6-hydroxydopamine) and Ξ±-synuclein: a unifying hypothesis. | Zhu BT | β | 2026 | β |
| Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway. | Welling MS et al. | β | 2025 | β |
| Electronic Properties of Small Psychotropic Substances in WaterξΈPhenylamines. | BoΔa R et al. | β | 2025 | β |
| Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine. | Avram M et al. | β | 2025 | β |
| Vestibular modulation by stimulant derivatives in a pentameric ligand-gated ion channel. | Karlsson E et al. | β | 2025 | β |
| Different Doses of Methamphetamine Are Needed to Produce Locomotor or Blood Pressure Sensitization in Mice. | Busceti CL et al. | β | 2024 | β |
| Effective Connectivity of Thalamocortical Interactions Following d-Amphetamine, LSD, and MDMA Administration. | Avram M et al. | β | 2024 | β |
| Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study. | Druckrey-Fiskaaen KT et al. | β | 2024 | β |
| Long-life triclosan exposure induces ADHD-like behavior in rats via prefrontal cortex dopaminergic deficiency. | Cui H et al. | β | 2024 | β |
| Neuronal activation of nucleus accumbens by local methamphetamine administration induces cognitive impairment through microglial inflammation in mice. | Kusui Y et al. | β | 2024 | β |
| Simulated Dopamine Modulation of a Neurorobotic Model of the Basal Ganglia. | Prescott TJ et al. | β | 2024 | β |
| Context is a Critical for Psychoactive Drug Effects. | Greenway KT | β | 2023 | β |
| Inefficacy of N-acetylcysteine in mitigating cue-induced amphetamine-seeking. | Fort TD et al. | β | 2023 | β |
| Metabolic profiles in plasma of patients with herpes labialis based on GC-MS. | Luo M et al. | β | 2023 | β |
| Central nervous system stimulants promote nerve cell death under continuous hypoxia. | Ikeda-Murakami K et al. | β | 2022 | β |
| Characterizing Thalamocortical (Dys)connectivity Following D-Amphetamine, LSD, and MDMA Administration. | Avram M et al. | β | 2022 | β |
| Methamphetamine Exposure During Development Causes Lasting Changes to Mesolimbic Dopamine Signaling in Mice. | Torres DJ et al. | β | 2022 | β |
| Screening for Cognitive Dysfunction in Amphetamine Users in Saudi Arabia; a Case-control Investigation Using Propensity Score Matching Analysis. | Osman M et al. | β | 2022 | β |
| Treatment of Acquired Hypothalamic Obesity: Now and the Future. | Dimitri P | β | 2022 | β |
| A Case for Thalamic Mechanisms of Schizophrenia: Perspective From Modeling 22q11.2 Deletion Syndrome. | Jiang Y et al. | β | 2021 | β |
| Distinct dose-dependent effects of methamphetamine on real-time dopamine transmission in the rat nucleus accumbens and behaviors. | Bhimani RV et al. | β | 2021 | β |
| Dopamine and the interdependency of time perception and reward. | Fung BJ et al. | β | 2021 | β |
| Escalating dose-multiple binge methamphetamine treatment elicits neurotoxicity, altering gut microbiota and fecal metabolites in mice. | Chen LJ et al. | β | 2021 | β |
| Functional connectivity abnormalities underlying mood disturbances in male abstinent methamphetamine abusers. | Jiang P et al. | β | 2021 | β |
| Genome-wide association study of stimulant dependence. | Cox J et al. | β | 2021 | β |
| Glutamate homeostasis and dopamine signaling: Implications for psychostimulant addiction behavior. | Fischer KD et al. | β | 2021 | β |
| Neuroplasticity and Multilevel System of Connections Determine the Integrative Role of Nucleus Accumbens in the Brain Reward System. | Bayassi-Jakowicka M et al. | β | 2021 | β |
| Occurrence, bioaccumulation and toxicological effect of drugs of abuse in aquatic ecosystem: A review. | Chen L et al. | β | 2021 | β |
| Pharmacotherapeutic strategies for treating cocaine use disorder-what do we have to offer? | Brandt L et al. | β | 2021 | β |
| PKC inhibition decreases amphetamine-maintained responding under a progressive-ratio schedule of reinforcement. | Altshuler RD et al. | β | 2021 | β |
| Protective Effect of Cinnamaldehyde on METH-induced Neurotoxicity in PC12 Cells via Inhibition of Apoptotic Response and Oxidative Stress. | Rashidi R et al. | β | 2021 | β |
| Samidorphan, an opioid receptor antagonist, attenuates drug-induced increases in extracellular dopamine concentrations and drug self-administration in male Wistar rats. | Cunningham JI et al. | β | 2021 | β |
| Selenoprotein P Modulates Methamphetamine Enhancement of Vesicular Dopamine Release in Mouse Nucleus Accumbens Via Dopamine D2 Receptors. | Torres DJ et al. | β | 2021 | β |
| Serotonin/dopamine interaction: Electrophysiological and neurochemical evidence. | De DeurwaerdΓ¨re P et al. | β | 2021 | β |
| Sex differences in vulnerability to addiction. | Quigley JA et al. | β | 2021 | β |
| Substance-Induced Psychoses: An Updated Literature Review. | Fiorentini A et al. | β | 2021 | β |
| Suggesting 7,8-dihydroxyflavone as a promising nutraceutical against CNS disorders. | Paul R et al. | β | 2021 | β |
| Activation of mGluR5 and NMDA Receptor Pathways in the Rostral Ventrolateral Medulla as a Central Mechanism for Methamphetamine-Induced Pressor Effect in Rats. | Lai CC et al. | β | 2020 | β |
| Effects of different sweeteners on behavior and neurotransmitters release in mice. | Yin KJ et al. | β | 2020 | β |
| How Important Is the Use of Cocaine and Amphetamines in the Development of Parkinson Disease? A Computational Study. | Pregeljc D et al. | β | 2020 | β |
| Investigation of serum and brain superoxide dismutase levels depending on atomoxetine used in attention-deficit/hyperactivity disorder treatment: A combination of in vivo and molecular docking studies. | GΓΌr F et al. | β | 2020 | β |
| Non-pharmacological factors that determine drug use and addiction. | Ahmed SH et al. | β | 2020 | β |
| The Appetite Suppressant D-norpseudoephedrine (Cathine) Acts <i>via</i> D1/D2-Like Dopamine Receptors in the Nucleus Accumbens Shell. | Kalyanasundar B et al. | β | 2020 | β |
| Amphetamine Self-Administration and Its Extinction Alter the 5-HT<sub>1B</sub> Receptor Protein Levels in Designated Structures of the Rat Brain. | Miszkiel J et al. | β | 2019 | β |
| Bipolar Disorder: Its Etiology and How to Model in Rodents. | Freund N et al. | β | 2019 | β |
| Chemoinformatic Consideration of Novel Psychoactive Substances: Compilation and Preliminary Analysis of a Categorised Dataset. | Firman JW et al. | β | 2019 | β |
| Genetics of cocaine and methamphetamine consumption and preference in Drosophila melanogaster. | Highfill CA et al. | β | 2019 | β |
| The Potential Influence of the Bacterial Microbiome on the Development and Progression of ADHD. | Bull-Larsen S et al. | β | 2019 | β |
| The protein kinase CΞ²-selective inhibitor, enzastaurin, attenuates amphetamine-stimulated locomotor activity and self-administration behaviors in rats. | Altshuler RD et al. | β | 2019 | β |
| Treatment of Hypothalamic Obesity with Dextroamphetamine: A Case Series. | Denzer C et al. | β | 2019 | β |
| Variability of non-clinical behavioral CNS safety assessment: An intercompany comparison. | Himmel HM et al. | β | 2019 | β |
| An Argument for Amphetamine-Induced Hallucinations in an Invertebrate. | Lee AH et al. | β | 2018 | β |
| Experimental Intrastriatal Applications of Botulinum Neurotoxin-A: A Review. | Hawlitschka A et al. | β | 2018 | β |
| Genetics of Cocaine and Methamphetamine Consumption and Preference in<i>Drosophila melanogaster</i> | Highfill CA et al. | β | 2018 | β |
| Human Drug Discrimination: Elucidating the Neuropharmacology of Commonly Abused Illicit Drugs. | Bolin BL et al. | β | 2018 | β |
| Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. | Osland ST et al. | β | 2018 | β |
| Repeated Administration of D-Amphetamine Induces Distinct Alterations in Behavior and Metabolite Levels in 129Sv and Bl6 Mouse Strains. | Vanaveski T et al. | β | 2018 | β |
| Animal models for bipolar disorder: from bedside to the cage. | Beyer DKE et al. | β | 2017 | β |
| Cross-talk between the epigenome and neural circuits in drug addiction. | Mews P et al. | β | 2017 | β |
| Effects of alkaloid-rich extract from Mitragyna speciosa (Korth.) Havil. on naloxone-precipitated morphine withdrawal symptoms and local field potential in the nucleus accumbens of mice. | Cheaha D et al. | β | 2017 | β |
| Effects of nucleus accumbens amphetamine administration on performance in a delay discounting task. | Orsini CA et al. | β | 2017 | β |
| Hypersomnia: Evaluation, Treatment, and Social and Economic Aspects. | Saini P et al. | β | 2017 | β |
| Neuronal Stress and Injury Caused by HIV-1, cART and Drug Abuse: Converging Contributions to HAND. | Sanchez AB et al. | β | 2017 | β |
| Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications. | De DeurwaerdΓ¨re P et al. | β | 2017 | β |
| The Effect of Methylphenidate on the Microstructure of Schedule-Induced Polydipsia in an animal model of ADHD. | Γbias J et al. | β | 2017 | β |
| Tics in the Pediatric Population: Pragmatic Management. | Ganos C et al. | β | 2017 | β |
| Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids. | Covey DP et al. | β | 2016 | β |
| Brain Histamine N-Methyltransferase As a Possible Target of Treatment for Methamphetamine Overdose. | Kitanaka J et al. | β | 2016 | β |
| Dopamine transporter mutant animals: a translational perspective. | Efimova EV et al. | β | 2016 | β |
| Effects of dopamine agents on a schedule-induced polydipsia procedure in the spontaneously hypertensive rat and in Wistar control rats. | Γbias J et al. | β | 2016 | β |
| Foxa1 is essential for development and functional integrity of the subthalamic nucleus. | Gasser E et al. | β | 2016 | β |
| L-DOPA elicits non-vesicular releases of serotonin and dopamine in hemiparkinsonian rats in vivo. | Miguelez C et al. | β | 2016 | β |
| Occurrence and Potential Biological Effects of Amphetamine on Stream Communities. | Lee SS et al. | β | 2016 | β |
| The individual and combined effects of phenmetrazine and mgluR2/3 agonist LY379268 on the motivation to self-administer cocaine. | Karkhanis AN et al. | β | 2016 | β |
| Amphetamines, new psychoactive drugs and the monoamine transporter cycle. | Sitte HH et al. | β | 2015 | β |
| Argon blocks the expression of locomotor sensitization to amphetamine through antagonism at the vesicular monoamine transporter-2 and mu-opioid receptor in the nucleus accumbens. | David HN et al. | β | 2015 | β |
| Attention-deficit/hyperactivity disorder in relation to addictive behaviors: a moderated-mediation analysis of personality-risk factors and sex. | Davis C et al. | β | 2015 | β |
| Catecholaminergic contributions to vocal communication signals. | Matheson LE et al. | β | 2015 | β |
| Cognitive judgment bias in the psychostimulant-induced model of mania in rats. | Rygula R et al. | β | 2015 | β |
| D1 and D2 antagonists reverse the effects of appetite suppressants on weight loss, food intake, locomotion, and rebalance spiking inhibition in the rat NAc shell. | Kalyanasundar B et al. | β | 2015 | β |
| Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8-deficient mice. | Bosse KE et al. | β | 2015 | β |
| Neonatal exposure to amphetamine alters social affiliation and central dopamine activity in adult male prairie voles. | Fukushiro DF et al. | β | 2015 | β |
| Pedunculopontine arousal system physiology-Effects of psychostimulant abuse. | Urbano FJ et al. | β | 2015 | β |
| Physiological and behavioral effects of amphetamine in BACE1(-/-) mice. | Paredes RM et al. | β | 2015 | β |
| Testosterone attenuates and the selective estrogen receptor modulator, raloxifene, potentiates amphetamine-induced locomotion in male rats. | Purves-Tyson TD et al. | β | 2015 | β |
| The modulatory action of harmane on serotonergic neurotransmission in rat brain. | Abu Ghazaleh H et al. | β | 2015 | β |
| The role of serotonin in drug use and addiction. | MΓΌller CP et al. | β | 2015 | β |
| 7,8-Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine. | Ren Q et al. | β | 2014 | β |
| Agmatine attenuates methamphetamine-induced hyperlocomotion and stereotyped behavior in mice. | Kitanaka N et al. | β | 2014 | β |
| A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). | Sharma A et al. | β | 2014 | β |
| Behavioral and neurochemical changes induced by repetitive combined treatments of ketamine and amphetamine in mice. | Lai CC et al. | β | 2014 | β |
| Deletion of SHATI/NAT8L increases dopamine D1 receptor on the cell surface in the nucleus accumbens, accelerating methamphetamine dependence. | Toriumi K et al. | β | 2014 | β |
| Digital holographic microscopy discriminates sex differences in medial prefrontal cortex GABA neurons following amphetamine sensitization. | Cholanian M et al. | β | 2014 | β |
| Influence of neonatal tactile stimulation on amphetamine preference in young rats: parameters of addiction and oxidative stress. | Antoniazzi CT et al. | β | 2014 | β |
| Long-term reduction of cocaine self-administration in rats treated with adenoviral vector-delivered cocaine hydrolase: evidence for enzymatic activity. | Zlebnik NE et al. | β | 2014 | β |
| Minocycline, an antibiotic with inhibitory effect on microglial activation, attenuates the maintenance and reinstatement of methamphetamine-seeking behavior in rat. | Attarzadeh-Yazdi G et al. | β | 2014 | β |
| Nicotine and methamphetamine disrupt habituation of sensory reinforcer effectiveness in male rats. | Lloyd DR et al. | β | 2014 | β |
| Relationships between sleep and addiction: the role of drug-environment conditioning. | Berro LF et al. | β | 2014 | β |
| Treatment of disorders of hypersomnolence. | Adenuga O et al. | β | 2014 | β |
| WITHDRAWN: Treatment for amphetamine dependence and abuse. | Srisurapanont M et al. | β | 2014 | β |
| Agonist replacement for stimulant dependence: a review of clinical research. | Stoops WW et al. | β | 2013 | β |
| Amphetamine augments vesicular dopamine release in the dorsal and ventral striatum through different mechanisms. | Avelar AJ et al. | β | 2013 | β |
| Background, clinical features and treatment of attention deficit hyperactivity disorder in children. | Warikoo N et al. | β | 2013 | β |
| Behavioral effects of bidirectional modulators of brain monoamines reserpine and d-amphetamine in zebrafish. | Kyzar E et al. | β | 2013 | β |
| Cue-evoked cocaine "craving": role of dopamine in the accumbens core. | Saunders BT et al. | β | 2013 | β |
| Episodic memories and their relevance for psychoactive drug use and addiction. | MΓΌller CP | β | 2013 | β |
| Implications of genome wide association studies for addiction: are our a priori assumptions all wrong? | Hall FS et al. | β | 2013 | β |
| Low dopamine D5 receptor density in hippocampus in an animal model of attention-deficit/hyperactivity disorder (ADHD). | Medin T et al. | β | 2013 | β |
| Melatonin attenuates methamphetamine-induced disturbances in mitochondrial dynamics and degeneration in neuroblastoma SH-SY5Y cells. | Parameyong A et al. | β | 2013 | β |
| Methamphetamine decreases levels of glutathione peroxidases 1 and 4 in SH-SY5Y neuronal cells: protective effects of selenium. | Barayuga SM et al. | β | 2013 | β |
| Methamphetamine-induced behavioral sensitization in a rodent model of posttraumatic stress disorder. | Eagle AL et al. | β | 2013 | β |
| Neural correlates of motor vigour and motor urgency during exercise. | Rauch HG et al. | β | 2013 | β |
| Subcortical dopaminergic deficits in a DISC1 mutant model: a study in direct reference to human molecular brain imaging. | Jaaro-Peled H et al. | β | 2013 | β |
| The effects of locus coeruleus and norepinephrine in methamphetamine toxicity. | Ferrucci M et al. | β | 2013 | β |
| A comparison of methylphenidate-, amphetamine-, and methamphetamine-induced hyperthermia and neurotoxicity in male Sprague-Dawley rats during the waking (lights off) cycle. | Levi MS et al. | β | 2012 | β |
| Adolescent rat circadian activity is modulated by psychostimulants. | Bergheim M et al. | β | 2012 | β |
| Advancing addiction treatment: what can we learn from animal studies? | Wu PH et al. | β | 2012 | β |
| Agonist replacement therapy for cocaine dependence: a translational review. | Rush CR et al. | β | 2012 | β |
| Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable? | Bramness JG et al. | β | 2012 | β |
| Ca(2+)/calmodulin-dependent protein kinase IIΞ± (Ξ±CaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome. | Steinkellner T et al. | β | 2012 | β |
| Differential action of methamphetamine on tyrosine hydroxylase and dopamine transport in the nigrostriatal pathway of ΞΌ-opioid receptor knockout mice. | Park SW et al. | β | 2012 | β |
| Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats. | Baarendse PJ et al. | β | 2012 | β |
| Effects of the Ξ±β-adrenergic agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine in healthy volunteers. | Hysek CM et al. | β | 2012 | β |
| Genetic factors modulating the response to stimulant drugs in humans. | Hart AB et al. | β | 2012 | β |
| Histamine: an undercover agent in multiple rare diseases? | Pino-Γngeles A et al. | β | 2012 | β |
| In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers. | Narendran R et al. | β | 2012 | β |
| Male injection drug users try new drugs following U.S. deportation to Tijuana, Mexico. | Robertson AM et al. | β | 2012 | β |
| Methamphetamine mimics the neurochemical profile of aging in rats and impairs recognition memory. | Melo P et al. | β | 2012 | β |
| Neuroeconomics: a bridge for translational research. | Sharp C et al. | β | 2012 | β |
| One day of motor training with amphetamine impairs motor recovery following spinal cord injury. | Wong JK et al. | β | 2012 | β |
| Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine. | Chen H et al. | β | 2012 | β |
| Role of dopamine receptors in ADHD: a systematic meta-analysis. | Wu J et al. | β | 2012 | β |
| S(+)amphetamine induces a persistent leak in the human dopamine transporter: molecular stent hypothesis. | Rodriguez-Menchaca AA et al. | β | 2012 | β |
| The effect of serotonin 5HT1B receptor ligands on amphetamine self-administration in rats. | Miszkiel J et al. | β | 2012 | β |
| 3-(Fur-2-yl)-10-(2-phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a novel adenosine receptor antagonist with A(2A)-mediated neuroprotective effects. | Scatena A et al. | β | 2011 | β |
| Alterations in striatal oxidative stress level produced by pharmacological manipulation of dopamine as shown by a novel synthetic marker molecule. | Aluf Y et al. | β | 2011 | β |
| An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. | Wilens TE et al. | β | 2011 | β |
| Drugs as instruments: a new framework for non-addictive psychoactive drug use. | MΓΌller CP et al. | β | 2011 | β |
| High doses of amphetamine augment, rather than disrupt, exocytotic dopamine release in the dorsal and ventral striatum of the anesthetized rat. | Ramsson ES et al. | β | 2011 | β |
| Histamine H3 receptor agonists decrease hypothalamic histamine levels and increase stereotypical biting in mice challenged with methamphetamine. | Kitanaka J et al. | β | 2011 | β |
| How addictive drugs disrupt presynaptic dopamine neurotransmission. | Sulzer D | β | 2011 | β |
| Knocking down the transcript of protein kinase C-lambda modulates hypothalamic glutathione peroxidase, melanocortin receptor and neuropeptide Y gene expression in amphetamine-treated rats. | Hsieh YS et al. | β | 2011 | β |
| Lateral thinking about leptin: a review of leptin action via the lateral hypothalamus. | Leinninger GM | β | 2011 | β |
| Local pretreatment with the cannabinoid CB1 receptor antagonist AM251 attenuates methamphetamine intra-accumbens self-administration. | Rodriguez JS et al. | β | 2011 | β |
| Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans. | Sofuoglu M et al. | β | 2011 | β |
| Monoclonal antibodies as pharmacokinetic antagonists for the treatment of (+)-methamphetamine addiction. | Owens SM et al. | β | 2011 | β |
| Nicotine ameliorates impairment of working memory in methamphetamine-treated rats. | Mizoguchi H et al. | β | 2011 | β |
| Partial inactivation of Ankrd26 causes diabetes with enhanced insulin responsiveness of adipose tissue in mice. | Raciti GA et al. | β | 2011 | β |
| Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders. | Pringsheim T et al. | β | 2011 | β |
| Presynaptic control of serotonin on striatal dopamine function. | Navailles S et al. | β | 2011 | β |
| Role of serotonin 5-HT1B receptors in psychostimulant addiction. | Miszkiel J et al. | β | 2011 | β |
| Roles of a novel molecule 'shati' in the development of methamphetamine-induced dependence. | Niwa M et al. | β | 2011 | β |
| SLC6 neurotransmitter transporters: structure, function, and regulation. | Kristensen AS et al. | β | 2011 | β |
| Synaptic plasticity and addiction: learning mechanisms gone awry. | Mameli M et al. | β | 2011 | β |
| Tamoxifen effects on respiratory chain complexes and creatine kinase activities in an animal model of mania. | Moretti M et al. | β | 2011 | β |
| The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease. | Mitchell RA et al. | β | 2011 | β |
| ΞΌ-Opioid receptors in the nucleus accumbens shell region mediate the effects of amphetamine on inhibitory control but not impulsive choice. | Wiskerke J et al. | β | 2011 | β |
| Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. | Faraone SV et al. | β | 2010 | β |
| Down-regulated GABAergic expression in the olfactory bulb layers of the mouse deficient in monoamine oxidase B and administered with amphetamine. | Yin HS et al. | β | 2010 | β |
| Effects of amphetamine on conditioned place preference and locomotion in the male green tree frog, Hyla cinerea. | Presley GM et al. | β | 2010 | β |
| Essential role of NMDA receptor channel Ξ΅4 subunit (GluN2D) in the effects of phencyclidine, but not methamphetamine. | Hagino Y et al. | β | 2010 | β |
| Influence of a low dose of amphetamine on vesicular monoamine transporter binding: a PET (+)[11C]DTBZ study in humans. | Boileau I et al. | β | 2010 | β |
| Interactions between the effects of early isolation rearing and complex housing on adult locomotor activity and sensitivity to amphetamine in rats involve noradrenergic neurotransmission. | Lomanowska AM et al. | β | 2010 | β |
| Low-dose pretreatment with clorgyline decreases the levels of 3-methoxy-4-hydroxyphenylglycol in the striatum and nucleus accumbens and attenuates methamphetamine-induced conditioned place preference in rats. | Kitanaka N et al. | β | 2010 | β |
| Meth/amphetamine use and associated HIV: Implications for global policy and public health. | Degenhardt L et al. | β | 2010 | β |
| Methanandamide blocks amphetamine-induced behavioral sensitization in rats. | Rasmussen BA et al. | β | 2010 | β |
| REM sleep deprivation produces a motivational deficit for food reward that is reversed by intra-accumbens amphetamine in rats. | Hanlon EC et al. | β | 2010 | β |
| Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models. | Jaaro-Peled H et al. | β | 2010 | β |
| Role of the prefrontal cortex and nucleus accumbens in reinstating methamphetamine seeking. | Rocha A et al. | β | 2010 | β |
| Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerization. | Wang M et al. | β | 2010 | β |
| The clinical toxicology of metamfetamine. | Schep LJ et al. | β | 2010 | β |
| The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters--why amphetamines take two to tango. | Sitte HH et al. | β | 2010 | β |
| The vascular effects of trace amines and amphetamines. | Broadley KJ | β | 2010 | β |
| Transgenic mice in the study of drug addiction and the effects of psychostimulant drugs. | Sora I et al. | β | 2010 | β |
| A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters. | Robertson SD et al. | β | 2009 | β |
| Amphetamine-evoked changes of oxidative stress and neuropeptide Y gene expression in hypothalamus: regulation by the protein kinase C-delta signaling. | Kuo DY et al. | β | 2009 | β |
| Aripiprazole and haloperidol suppress excessive dopamine release in the amygdala in response to conditioned fear stress, but show contrasting effects on basal dopamine release in methamphetamine-sensitized rats. | Oshibuchi H et al. | β | 2009 | β |
| Atomoxetine attenuates dextroamphetamine effects in humans. | Sofuoglu M et al. | β | 2009 | β |
| Attenuation of the effects of d-amphetamine on interval timing behavior by central 5-hydroxytryptamine depletion. | Body S et al. | β | 2009 | β |
| Conditioned cues and the expression of stimulant sensitization in animals and humans. | Vezina P et al. | β | 2009 | β |
| Differential alterations in the relations among GABAergic, catecholaminergic and calcium binding protein expression in the olfactory bulb of amphetamine-administered mouse. | Yin HS et al. | β | 2009 | β |
| Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines. | Duryee MJ et al. | β | 2009 | β |
| Monoamine transporter as a target molecule for psychostimulants. | Sora I et al. | β | 2009 | β |
| The effect of N-acetylcysteine on amphetamine-mediated dopamine release in rat brain striatal slices by ion-pair reversed-phase high performance liquid chromatography. | Gere-PΓ‘szti E et al. | β | 2009 | β |
| The PKC inhibitor Ro31-8220 blocks acute amphetamine-induced dopamine overflow in the nucleus accumbens. | Loweth JA et al. | β | 2009 | β |
| Acute dextro-amphetamine administration does not alter brain myo-inositol levels in humans and animals: MRS investigations at 3 and 18.8 T. | McGrath BM et al. | β | 2008 | β |
| Acute increase of the glutamate-glutamine cycling in discrete brain areas after administration of a single dose of amphetamine. | Pereira FC et al. | β | 2008 | β |
| Adenosine A(2A) receptors and their role in drug addiction. | Brown RM et al. | β | 2008 | β |
| Alterations in the levels of heterotrimeric G protein subunits induced by psychostimulants, opiates, barbiturates, and ethanol: Implications for drug dependence, tolerance, and withdrawal. | Kitanaka N et al. | β | 2008 | β |
| Association between polymorphisms in the vesicle-associated membrane protein-associated protein A (VAPA) gene on chromosome 18p and bipolar disorder. | Lohoff FW et al. | β | 2008 | β |
| Blockade of M1 muscarinic acetylcholine receptors modulates the methamphetamine-induced psychomotor stimulant effect. | Lee KW et al. | β | 2008 | β |
| Calcium-dependent mechanisms of the reinstatement of nicotine-conditioned place preference by drug priming in rats. | Biala G et al. | β | 2008 | β |
| Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans. | Ersche KD et al. | β | 2008 | β |
| Dissociation between long-lasting behavioral sensitization to amphetamine and impulsive choice in rats performing a delay-discounting task. | Stanis JJ et al. | β | 2008 | β |
| Disulfiram enhances subjective effects of dextroamphetamine in humans. | Sofuoglu M et al. | β | 2008 | β |
| Dopamine transporter mutant mice in experimental neuropharmacology. | Gainetdinov RR | β | 2008 | β |
| Drug addiction as a pathology of staged neuroplasticity. | Kalivas PW et al. | β | 2008 | β |
| Effect of the new antiepileptic drug retigabine in a rodent model of mania. | Dencker D et al. | β | 2008 | β |
| Effects of tryptophan deficiency on prepulse inhibition of the acoustic startle in rats. | Bortolato M et al. | β | 2008 | β |
| Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioral, and neurotoxic effects of methamphetamine. | Weinshenker D et al. | β | 2008 | β |
| Glutamate release in the nucleus accumbens core is necessary for heroin seeking. | LaLumiere RT et al. | β | 2008 | β |
| Hyperthermic and lethal effects of methamphetamine: roles of dopamine D1 and D2 receptors. | Ito M et al. | β | 2008 | β |
| Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice. | Qi J et al. | β | 2008 | β |
| Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area. | Argilli E et al. | β | 2008 | β |
| Methamphetamine-associated acute left ventricular dysfunction: a variant of stress-induced cardiomyopathy. | Srikanth S et al. | β | 2008 | β |
| Methamphetamine-elicited alterations of dopamine- and serotonin-metabolite levels within mu-opioid receptor knockout mice: a microdialysis study. | Lan KC et al. | β | 2008 | β |
| Neurochemical consequences of dysphoric state during amphetamine withdrawal in animal models: a review. | Kitanaka J et al. | β | 2008 | β |
| Neurotensin in the ventral pallidum increases extracellular gamma-aminobutyric acid and differentially affects cue- and cocaine-primed reinstatement. | Torregrossa MM et al. | β | 2008 | β |
| Protein expression profile in the amygdala of rats with methamphetamine-induced behavioral sensitization. | Iwazaki T et al. | β | 2008 | β |
| Riluzole and D-amphetamine interactions in humans. | Sofuoglu M et al. | β | 2008 | β |
| Safety pharmacology assessment of central nervous system function in juvenile and adult rats: effects of pharmacological reference compounds. | Himmel HM | β | 2008 | β |
| The neurocircuitry of addiction: an overview. | Feltenstein MW et al. | β | 2008 | β |
| The selective delta opioid agonist SNC80 enhances amphetamine-mediated efflux of dopamine from rat striatum. | Bosse KE et al. | β | 2008 | β |
| Adderall produces increased striatal dopamine release and a prolonged time course compared to amphetamine isomers. | Joyce BM et al. | β | 2007 | β |
| An inducer for glial cell line-derived neurotrophic factor and tumor necrosis factor-alpha protects against methamphetamine-induced rewarding effects and sensitization. | Niwa M et al. | β | 2007 | β |
| A novel molecule "shati" is involved in methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference. | Niwa M et al. | β | 2007 | β |
| Behavioral and biochemical effects of various food-restriction regimens in the rats. | MarinkoviΔ P et al. | β | 2007 | β |
| Catecholamine mapping within nucleus accumbens: differences in basal and amphetamine-stimulated efflux of norepinephrine and dopamine in shell and core. | McKittrick CR et al. | β | 2007 | β |
| Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity. | Kalivas PW | β | 2007 | β |
| Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain. | Easton N et al. | β | 2007 | β |
| Effects of amphetamine on serotoninergic and GABAergic expression of developing brain. | Yin HS et al. | β | 2007 | β |
| Functional internal complexity of amygdala: focus on gene activity mapping after behavioral training and drugs of abuse. | Knapska E et al. | β | 2007 | β |
| Intracerebral administration of protein kinase A or cAMP response element-binding protein antisense oligonucleotide can modulate amphetamine-mediated appetite suppression in free-moving rats. | Hsieh YS et al. | β | 2007 | β |
| Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice. | Tatsuta T et al. | β | 2007 | β |
| Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling. | Melega WP et al. | β | 2007 | β |
| Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. | Numachi Y et al. | β | 2007 | β |
| Methamphetamine-induced locomotor activity and sensitization in dopamine transporter and vesicular monoamine transporter 2 double mutant mice. | Fukushima S et al. | β | 2007 | β |
| Methamphetamine induces ectopic expression of tyrosine hydroxylase and increases noradrenaline levels within the cerebellar cortex. | Ferrucci M et al. | β | 2007 | β |
| Modeling the role of environment in addiction. | Caprioli D et al. | β | 2007 | β |
| Neurobiology of cocaine addiction: implications for new pharmacotherapy. | Kalivas PW | β | 2007 | β |
| Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms. | Cadet JL et al. | β | 2007 | β |
| Nrf2 gene deletion fails to alter psychostimulant-induced behavior or neurotoxicity. | Pacchioni AM et al. | β | 2007 | β |
| Protein expression profile in the striatum of rats with methamphetamine-induced behavioral sensitization. | Iwazaki T et al. | β | 2007 | β |
| Repeated cocaine administration impairs group II metabotropic glutamate receptor-mediated long-term depression in rat medial prefrontal cortex. | Huang CC et al. | β | 2007 | β |
| Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol. | Nagai T et al. | β | 2007 | β |
| Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice. | Ago Y et al. | β | 2007 | β |
| Role of endogenous release of norepinephrine in muscle spasms after chronic spinal cord injury. | Rank MM et al. | β | 2007 | β |
| Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors. | MΓΌller CP et al. | β | 2007 | β |
| Simple transporter trafficking model for amphetamine-induced dopamine efflux. | Thwar PK et al. | β | 2007 | β |
| Susceptibility genes for schizophrenia: characterisation of mutant mouse models at the level of phenotypic behaviour. | O'Tuathaigh CM et al. | β | 2007 | β |
| The influence of amphetamine on sensory and conditioned reinforcement: evidence for the re-selection hypothesis of dopamine function. | Winterbauer NE et al. | β | 2007 | β |
| The neuropsychology of amphetamine and opiate dependence: implications for treatment. | Ersche KD et al. | β | 2007 | β |
| Tumor necrosis factor-alpha and its inducer inhibit morphine-induced rewarding effects and sensitization. | Niwa M et al. | β | 2007 | β |
| Valproate and acetyl-L-carnitine prevent methamphetamine-induced behavioral sensitization in mice. | Coccurello R et al. | β | 2007 | β |
| Activations of c-fos/c-jun signaling are involved in the modulation of hypothalamic superoxide dismutase (SOD) and neuropeptide Y (NPY) gene expression in amphetamine-mediated appetite suppression. | Hsieh YS et al. | β | 2006 | β |
| Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D1 and D2 dopamine receptors. | Schwendt M et al. | β | 2006 | β |
| Behavioral disinhibition requires dopamine receptor activation. | van Gaalen MM et al. | β | 2006 | β |
| Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein. | Fleming SM et al. | β | 2006 | β |
| Central nervous system stimulants and sport practice. | Avois L et al. | β | 2006 | β |
| Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats. | Ball KT et al. | β | 2006 | β |
| Critical involvement of dopaminergic neurotransmission in impulsive decision making. | van Gaalen MM et al. | β | 2006 | β |
| Currents in neurotransmitter transporters. | Gerstbrein K et al. | β | 2006 | β |
| DDD mice, a novel acute mouse model of Parkinson's disease. | Sotnikova TD et al. | β | 2006 | β |
| Dexamphetamine use for management of obesity and hypersomnolence following hypothalamic injury. | Ismail D et al. | β | 2006 | β |
| Differential effects of chronic amphetamine and baclofen administration on cAMP levels and phosphorylation of CREB in distinct brain regions of wild type and monoamine oxidase B-deficient mice. | Yin HS et al. | β | 2006 | β |
| Early life tactile stimulation changes adult rat responsiveness to amphetamine. | Lovic V et al. | β | 2006 | β |
| Impact of basic FGF expression in astrocytes on dopamine neuron synaptic function and development. | Forget C et al. | β | 2006 | β |
| Lobeline attenuates methamphetamine-induced stereotypy in adolescent mice. | Tatsuta T et al. | β | 2006 | β |
| Methamphetamine-related sudden death with a concentration which was of a 'toxic level'. | Inoue H et al. | β | 2006 | β |
| Methamphetamine reward in mice as assessed by conditioned place preference test with Supermex sensors: effect of subchronic clorgyline pretreatment. | Kitanaka N et al. | β | 2006 | β |
| Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions. | Kitanaka J et al. | β | 2006 | β |
| New developments in the treatment of attention-deficit/hyperactivity disorder in primary care. | β | β | 2006 | β |
| Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization. | David HN et al. | β | 2006 | β |
| Oligomerization of neurotransmitter transporters: a ticket from the endoplasmic reticulum to the plasma membrane. | Farhan H et al. | β | 2006 | β |
| Ontogeny of the adrenal response to (+)-methamphetamine in neonatal rats: the effect of prior drug exposure. | Williams MT et al. | β | 2006 | β |
| Profile of executive and memory function associated with amphetamine and opiate dependence. | Ersche KD et al. | β | 2006 | β |
| Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine. | Zhang L et al. | β | 2006 | β |
| Protein expression profile in the striatum of acute methamphetamine-treated rats. | Iwazaki T et al. | β | 2006 | β |
| Reinstatement of nicotine-conditioned place preference by drug priming: effects of calcium channel antagonists. | Biala G et al. | β | 2006 | β |
| The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? | Pierce RC et al. | β | 2006 | β |
| The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain. | Burchett SA et al. | β | 2006 | β |
| 2-Phenylethylamine in combination with l-deprenyl lowers the striatal level of dopamine and prolongs the duration of the stereotypy in mice. | Kitanaka J et al. | β | 2005 | β |
| 4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attention. | Cowart M et al. | β | 2005 | β |
| Amphetamine, an appetite suppressant, decreases neuropeptide Y immunoreactivity in rat hypothalamic paraventriculum. | Hsieh YS et al. | β | 2005 | β |
| Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone. | Chiu CT et al. | β | 2005 | β |
| Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry. | Callaghan PD et al. | β | 2005 | β |
| Different effects of chronic exposure to ELF magnetic field on spontaneous and amphetamine-induced locomotor and stereotypic activities in rats. | JanaΔ B et al. | β | 2005 | β |
| Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease. | Sotnikova TD et al. | β | 2005 | β |
| Effects of acute amphetamine administration on AMPA-mediated synaptic activity and expression of AMPA receptor subunit 2 of brain neurons. | Yu MF et al. | β | 2005 | β |
| Effects of monoamine oxidase inhibitors on methamphetamine-induced stereotypy in mice and rats. | Tatsuta T et al. | β | 2005 | β |
| Effects of the antidepressant trazodone, a 5-HT 2A/2C receptor antagonist, on dopamine-dependent behaviors in rats. | Balsara JJ et al. | β | 2005 | β |
| Inhibition of methamphetamine-induced hyperlocomotion in mice by clorgyline, a monoamine oxidase-a inhibitor, through alteration of the 5-hydroxytriptamine turnover in the striatum. | Kitanaka N et al. | β | 2005 | β |
| Involvement of hypothalamic neuropeptide Y in regulating the amphetamine-induced appetite suppression in streptozotocin diabetic rats. | Kuo DY | β | 2005 | β |
| Mechanisms of neurotransmitter release by amphetamines: a review. | Sulzer D et al. | β | 2005 | β |
| Monoclonal IgG affinity and treatment time alters antagonism of (+)-methamphetamine effects in rats. | Byrnes-Blake KA et al. | β | 2005 | β |
| Neurobiologic basis of nicotine addiction and psychostimulant abuse: a role for neurotensin? | Fredrickson P et al. | β | 2005 | β |
| Periadolescent rats (P41-50) exhibit increased susceptibility to D-methamphetamine-induced long-term spatial and sequential learning deficits compared to juvenile (P21-30 or P31-40) or adult rats (P51-60). | Vorhees CV et al. | β | 2005 | β |
| Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants. | Jayanthi LD et al. | β | 2005 | β |
| Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats. | Ball KT et al. | β | 2005 | β |
| Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphetamines. | Hilber B et al. | β | 2005 | β |
| STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating. | Fradley RL et al. | β | 2005 | β |
| The dopamine hypothesis of drug addiction: hypodopaminergic state. | Melis M et al. | β | 2005 | β |
| The neurophysiology of attention-deficit/hyperactivity disorder. | di Michele F et al. | β | 2005 | β |
| The role of tissue plasminogen activator in methamphetamine-related reward and sensitization. | Nagai T et al. | β | 2005 | β |
| The time-course of ribavirin-provoked changes of basal and AMPH-induced motor activities in rats. | JanaΔ B et al. | β | 2005 | β |
| Transcriptional involvement of protein kinase C-alpha isozyme in amphetamine-mediated appetite suppression. | Hsieh YS et al. | β | 2005 | β |
| Valproate attenuates dextroamphetamine-induced subjective changes more than lithium. | Willson MC et al. | β | 2005 | β |
| Aberrant responses in social interaction of dopamine transporter knockout mice. | Rodriguiz RM et al. | β | 2004 | β |
| Alprazolam attenuates the behavioral effects of d-amphetamine in humans. | Rush CR et al. | β | 2004 | β |
| Amphetamine-induced behavioral activation is associated with variable changes in basal ganglia output neurons recorded from awake, behaving rats. | Gulley JM et al. | β | 2004 | β |
| Anatomical substrates for the discriminative stimulus effects of methamphetamine in rats. | Nakajima A et al. | β | 2004 | β |
| An update on the pharmacotherapy of excessive daytime sleepiness and cataplexy. | Mignot E | β | 2004 | β |
| Calcium channel antagonists attenuate cross-sensitization to the rewarding and/or locomotor effects of nicotine, morphine and MK-801. | Biala G et al. | β | 2004 | β |
| Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices. | de la Torre R et al. | β | 2004 | β |
| D-amphetamine responses in catechol-O-methyltransferase (COMT) disrupted mice. | Huotari M et al. | β | 2004 | β |
| Dextroamphetamine causes a change in regional brain activity in vivo during cognitive tasks: a functional magnetic resonance imaging study of blood oxygen level-dependent response. | Willson MC et al. | β | 2004 | β |
| Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine. | Sotnikova TD et al. | β | 2004 | β |
| Drug-induced neurobehavioral plasticity: the role of environmental context. | Badiani A et al. | β | 2004 | β |
| Effects of psychotomimetic and antipsychotic agents on neocortical and striatal concentrations of various amino acids in the rat. | Sakurai S et al. | β | 2004 | β |
| Immunological consequences of methamphetamine protein glycation. | Dickerson TJ et al. | β | 2004 | β |
| Individual differences in cocaine- and amphetamine-induced activation of male Sprague-Dawley rats: contribution of the dopamine transporter. | Briegleb SK et al. | β | 2004 | β |
| Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter. | Gnegy ME et al. | β | 2004 | β |
| Maternal methamphetamine administration during pregnancy influences on fetal rat heart development. [corrected]. | Inoue H et al. | β | 2004 | β |
| Methamphetamine and brain histamine: a study using histamine-related gene knockout mice. | Iwabuchi K et al. | β | 2004 | β |
| Methamphetamine discrimination and in vivo microdialysis in squirrel monkeys. | Czoty PW et al. | β | 2004 | β |
| Non-linearity in combined effects of ELF magnetic field and amphetamine on motor activity in rats. | PesiΔ V et al. | β | 2004 | β |
| Quetiapine increases the firing rate of rat substantia nigra and ventral tegmental area dopamine neurons in vitro. | Werkman TR et al. | β | 2004 | β |
| Risperidone reduction of amphetamine-induced self-injurious behavior in mice. | Wagner GC et al. | β | 2004 | β |
| Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity. | Nakajima A et al. | β | 2004 | β |
| Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs. | Vezina P | β | 2004 | β |
| Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine. | Moroz IA et al. | β | 2004 | β |
| The effects of tiazofurin on basal and amphetamine-induced motor activity in rats. | JanaΔ B et al. | β | 2004 | β |
| Acute effects of 3,4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D(1) and D(2) receptors. | Ball KT et al. | β | 2003 | β |
| A developmentally regulated and psychostimulant-inducible novel rat gene mrt1 encoding PDZ-PX proteins isolated in the neocortex. | Kajii Y et al. | β | 2003 | β |
| Amphetamine enhances Ca2+ entry and catecholamine release via nicotinic receptor activation in bovine adrenal chromaffin cells. | Liu PS et al. | β | 2003 | β |
| An immunohistochemical examination of the effects of sensitisation on the mesotelencephalic dopaminergic response to d-amphetamine. | Phillips GD et al. | β | 2003 | β |
| Blockade of the locomotor stimulant effects of amphetamine by group I, group II, and group III metabotropic glutamate receptor ligands in the rat nucleus accumbens: possible interactions with dopamine receptors. | David HN et al. | β | 2003 | β |
| Both alpha1-adrenergic and D(1)-dopaminergic neurotransmissions are involved in phenylpropanolamine-mediated feeding suppression in mice. | Cheng JT et al. | β | 2003 | β |
| Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum. | Porras G et al. | β | 2003 | β |
| Cooperative activation of dopamine D1 and D2 receptors increases spike firing of nucleus accumbens neurons via G-protein betagamma subunits. | Hopf FW et al. | β | 2003 | β |
| Differential role of serotonergic projections arising from the dorsal and median raphe nuclei in locomotor hyperactivity and prepulse inhibition. | Kusljic S et al. | β | 2003 | β |
| Dopamine transporter: basic aspects and neuroimaging. | Piccini PP | β | 2003 | β |
| Drug therapy for adults with attention-deficit hyperactivity disorder. | Wilens TE | β | 2003 | β |
| Effects of dextroamphetamine, lithium chloride, sodium valproate and carbamazepine on intraplatelet Ca2+ levels. | Ulrich ML et al. | β | 2003 | β |
| Excitation by dopamine of rat subthalamic nucleus neurones in vitro-a direct action with unconventional pharmacology. | Tofighy A et al. | β | 2003 | β |
| Facilitation of ejaculation after methamphetamine administration in paradoxical sleep deprived rats. | Levy Andersen M et al. | β | 2003 | β |
| Further evidence for the mediation of both subtypes of dopamine D1/D2 receptors and cerebral neuropeptide Y (NPY) in amphetamine-induced appetite suppression. | Kuo DY | β | 2003 | β |
| Global 5-HT depletion attenuates the ability of amphetamine to decrease impulsive choice on a delay-discounting task in rats. | Winstanley CA et al. | β | 2003 | β |
| Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. | Narita M et al. | β | 2003 | β |
| Implication of Rho-associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats. | Narita M et al. | β | 2003 | β |
| Mediation of amphetamine-induced long-term depression of synaptic transmission by CB1 cannabinoid receptors in the rat amygdala. | Huang YC et al. | β | 2003 | β |
| Microdialysis studies of D-amphetamine-evoked striatal dopamine overflow in young versus aged F344 rats: effects of concentration and order of administration. | Purdom MS et al. | β | 2003 | β |
| Monoamine transporters: from genes to behavior. | Gainetdinov RR et al. | β | 2003 | β |
| On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization. | Vanderschuren LJ et al. | β | 2003 | β |
| Pharmacodynamic mechanisms of monoclonal antibody-based antagonism of (+)-methamphetamine in rats. | Byrnes-Blake KA et al. | β | 2003 | β |
| Pharmacology of drugs of abuse. | Reynolds EW et al. | β | 2003 | β |
| Plasma membrane monoamine transporters: structure, regulation and function. | Torres GE et al. | β | 2003 | β |
| Prenatal and neonatal exposure to bisphenol-A enhances the central dopamine D1 receptor-mediated action in mice: enhancement of the methamphetamine-induced abuse state. | Suzuki T et al. | β | 2003 | β |
| Repeated amphetamine treatment induces neurite outgrowth and enhanced amphetamine-stimulated dopamine release in rat pheochromocytoma cells (PC12 cells) via a protein kinase C- and mitogen activated protein kinase-dependent mechanism. | Park YH et al. | β | 2003 | β |
| Striatal dopaminergic stimulation produces c-Fos expression in the PPT and an increase in wakefulness. | Mena-Segovia J et al. | β | 2003 | β |
| Substance induced plasticity in noradrenergic innervation of the paraventricular hypothalamic nucleus. | Jansen AS et al. | β | 2003 | β |
| Suppressive effects of trihexyphenidyl on methamphetamine-induced dopamine release as measured by in vivo microdialysis. | Shimosato K et al. | β | 2003 | β |
| Viral restoration of dopamine to the nucleus accumbens is sufficient to induce a locomotor response to amphetamine. | Heusner CL et al. | β | 2003 | β |
| 5-HT(6) receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine. | Frantz KJ et al. | β | 2002 | β |
| Acute behavioral and physiological effects of modafinil in drug abusers. | Rush CR et al. | β | 2002 | β |
| Alteration of methamphetamine-induced striatal dopamine release in mint-1 knockout mice. | Mori A et al. | β | 2002 | β |
| Amphetamine usage and genital self-mutilation. | Israel JA et al. | β | 2002 | β |
| A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder. | Wilens TE et al. | β | 2002 | β |
| Behavioral pharmacology and timing. | Odum AL | β | 2002 | β |
| D-amphetamine fails to increase extracellular dopamine levels in mice lacking alpha 1b-adrenergic receptors: relationship between functional and nonfunctional dopamine release. | Auclair A et al. | β | 2002 | β |
| Discriminative-stimulus effects of modafinil in cocaine-trained humans. | Rush CR et al. | β | 2002 | β |
| Effect of amphetamine repeated treatment on the feeding behavior in neuropeptide Y-overexpressing mice. | Kuo DY et al. | β | 2002 | β |
| Effects of D-amphetamine in a temporal discrimination procedure: selective changes in timing or rate dependency? | Odum AL et al. | β | 2002 | β |
| Enhanced amphetamine-mediated dopamine release develops in PC12 cells after repeated amphetamine treatment. | Kantor L et al. | β | 2002 | β |
| Enhancement of delayed release of dopamine in the amygdala induced by conditioned fear stress in methamphetamine-sensitized rats. | Suzuki T et al. | β | 2002 | β |
| Functional aspects of dopamine metabolism in the putative prefrontal cortex analogue and striatum of pigeons (Columba livia). | Bast T et al. | β | 2002 | β |
| Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice. | Kubota Y et al. | β | 2002 | β |
| Informed decision-making on sympathomimetic use in sport and health. | Bouchard R et al. | β | 2002 | β |
| Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251. | VinklerovΓ‘ J et al. | β | 2002 | β |
| Monoamine transporter pharmacology and mutant mice. | Gainetdinov RR et al. | β | 2002 | β |
| Muscarinic, adenosine A(2) and histamine H(3) receptor modulation of haloperidol-induced c-fos expression in the striatum and nucleus accumbens. | Hussain N et al. | β | 2002 | β |
| No association for D2 and D4 dopamine receptor polymorphisms and methamphetamine abuse in Chinese males. | Tsai SJ et al. | β | 2002 | β |
| Persistent antagonism of methamphetamine-induced dopamine release in rats pretreated with GBR12909 decanoate. | Baumann MH et al. | β | 2002 | β |
| Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence. | Baumann MH et al. | β | 2002 | β |
| Repeated, intermittent treatment with amphetamine induces neurite outgrowth in rat pheochromocytoma cells (PC12 cells). | Park YH et al. | β | 2002 | β |
| Role of cerebral dopamine but not plasma insulin, leptin and glucocorticoid in the development of tolerance to the anorectic effect of amphetamine. | Kuo DY et al. | β | 2002 | β |
| The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids. | Zimmer L et al. | β | 2002 | β |
| The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers. | Wachtel SR et al. | β | 2002 | β |
| The emergence of potent forms of methamphetamine in Sydney, Australia: a case study of the IDRS as a strategic early warning system. | Topp L et al. | β | 2002 | β |
| The role of zinc ions in reverse transport mediated by monoamine transporters. | Scholze P et al. | β | 2002 | β |
| Ventral striatal anatomy of locomotor activity induced by cocaine, D-amphetamine, dopamine and D1/D2 agonists. | Ikemoto S | β | 2002 | β |
| Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. | Bunzow JR et al. | β | 2001 | β |
| Behavioral activation in rats requires endogenous ascorbate release in striatum. | Rebec GV et al. | β | 2001 | β |
| D3 dopamine receptor, behavioral sensitization, and psychosis. | Richtand NM et al. | β | 2001 | β |
| Dopamine characteristics in rat genotypes with distinct susceptibility to epileptic activity: apomorphine-induced stereotyped gnawing and novelty/amphetamine-induced locomotor stimulation. | de Bruin NM et al. | β | 2001 | β |
| Dopaminergic role in stimulant-induced wakefulness. | Wisor JP et al. | β | 2001 | β |
| Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity. | Yuan J et al. | β | 2001 | β |
| Generation of anti-(+)methamphetamine antibodies is not impeded by (+)methamphetamine administration during active immunization of rats. | Byrnes-Blake KA et al. | β | 2001 | β |
| Genetic animal models: focus on schizophrenia. | Gainetdinov RR et al. | β | 2001 | β |
| Halothane potentiates the effect of methamphetamine and nomifensine on extracellular dopamine levels in rat striatum: a microdialysis study. | Adachi YU et al. | β | 2001 | β |
| Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter. | Spielewoy C et al. | β | 2001 | β |
| Induction of the immediate early genes egr-1 and c-fos by methamphetamine in mouse brain. | Thiriet N et al. | β | 2001 | β |
| Locomotor-stimulating effects of indirect dopamine agonists are attenuated in Fawn hooded rats independent of postweaning social experience. | Hall FS et al. | β | 2001 | β |
| Methamphetamine concentrations in fetal and maternal brain following prenatal exposure. | Won L et al. | β | 2001 | β |
| Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. | Davidson C et al. | β | 2001 | β |
| Molecular mechanisms of neurotransmitter release. | Fon EA et al. | β | 2001 | β |
| Neurotoxicity of methamphetamine and methylenedioxymethamphetamine. | Seiden LS et al. | β | 2001 | β |
| Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment. | Gluck MR et al. | β | 2001 | β |
| Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder. | Markowitz JS et al. | β | 2001 | β |
| Role of mitochondrial dysfunction and dopamine-dependent oxidative stress in amphetamine-induced toxicity. | Lotharius J et al. | β | 2001 | β |
| Seizure activity and hyperthermia potentiate the increases in dopamine and serotonin extracellular levels in the amygdala during exposure to d-amphetamine. | Tor-Agbidye J et al. | β | 2001 | β |
| The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. | McFarland K et al. | β | 2001 | β |
| The role of the brain reward system in depression. | Naranjo CA et al. | β | 2001 | β |
| Treatment for amphetamine dependence and abuse. | Srisurapanont M et al. | β | 2001 | β |
| Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations. | Hogan KA et al. | β | 2000 | β |
| Central nervous system stimulants. | George AJ | β | 2000 | β |
| Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions. | Shirayama Y et al. | β | 2000 | β |
| Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. | Nicola SM et al. | β | 2000 | β |
| Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes. | Cowell RM et al. | β | 2000 | β |
| Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity. | Van Kampen JM et al. | β | 2000 | β |
| Effects of dopamine, NMDA, opiate, and serotonin-related agents on acute methamphetamine-induced self-injurious behavior in mice. | Shishido T et al. | β | 2000 | β |
| Intraneuronal dopamine-quinone synthesis: a review. | Sulzer D et al. | β | 2000 | β |
| Long T methamphetamine schedules produce circadian ensuing drug activity in rats. | Pecoraro N et al. | β | 2000 | β |
| Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. | Abeliovich A et al. | β | 2000 | β |
| Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse. | Rothman RB et al. | β | 2000 | β |
| Role for dopamine in malonate-induced damage in vivo in striatum and in vitro in mesencephalic cultures. | Moy LY et al. | β | 2000 | β |
| Amine weak bases disrupt vesicular storage and promote exocytosis in chromaffin cells. | Mundorf ML et al. | β | 1999 | β |
| Amphetamine depresses excitatory synaptic transmission via serotonin receptors in the ventral tegmental area. | Jones S et al. | β | 1999 | β |
| Amphetamine withdrawal: II. A placebo-controlled, randomised, double-blind study of amineptine treatment. | Srisurapanont M et al. | β | 1999 | β |
| Behavior-related changes in the activity of substantia nigra pars reticulata neurons in freely moving rats. | Gulley JM et al. | β | 1999 | β |
| Dopamine neuronal transport kinetics and effects of amphetamine. | Jones SR et al. | β | 1999 | β |
| Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo. | Lamensdorf I et al. | β | 1999 | β |
| Effects of lithium and amphetamine on inositol metabolism in the human brain as measured by 1H and 31P MRS. | Silverstone PH et al. | β | 1999 | β |
| Effects of pretreatment with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on methamphetamine pharmacokinetics and striatal dopamine losses. | Fornai F et al. | β | 1999 | β |
| Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons. | Scarponi M et al. | β | 1999 | β |
| Enhanced amphetamine- and K+-mediated dopamine release in rat striatum after repeated amphetamine: differential requirements for Ca2+- and calmodulin-dependent phosphorylation and synaptic vesicles. | Kantor L et al. | β | 1999 | β |
| Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine. | Gerasimov MR et al. | β | 1999 | β |
| GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scans. | Villemagne VL et al. | β | 1999 | β |
| Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. | Fumagalli F et al. | β | 1999 | β |
| Ion dependence of carrier-mediated release in dopamine or norepinephrine transporter-transfected cells questions the hypothesis of facilitated exchange diffusion. | Pifl C et al. | β | 1999 | β |
| Long-lasting sensitization to the accelerating effects of amphetamine on the speed of an internal clock. | Badiani A et al. | β | 1999 | β |
| Methamphetamine-induced neurotoxicity alters locomotor activity, stereotypic behavior, and stimulated dopamine release in the rat. | Wallace TL et al. | β | 1999 | β |
| Neuropeptide FF potentiates the behavioral sensitization to amphetamine and alters the levels of neurotransmitters in the medial prefrontal cortex. | Chen JC et al. | β | 1999 | β |
| Opposing role of dopamine D1 and D2 receptors in modulation of rat nucleus accumbens noradrenaline release. | Vanderschuren LJ et al. | β | 1999 | β |
| Release of endogenous dopamine in cultured mesencephalic neurons: influence of dopaminergic agonists and glucocorticoid antagonists. | RougΓ©-Pont F et al. | β | 1999 | β |
| Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. | Gainetdinov RR et al. | β | 1999 | β |
| The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum. | Gray AM et al. | β | 1999 | β |
| Time course of brain temperature and caudate/putamen microdialysate levels of amphetamine and dopamine in rats after multiple doses of d-amphetamine. | Clausing P et al. | β | 1999 | β |
| Transient increases of histamine H1 and H2 receptor mRNA levels in the rat striatum after the chronic administration of methamphetamine. | Kubota Y et al. | β | 1999 | β |
| Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty. | Badiani A et al. | β | 1998 | β |
| Amphetamine releases GABA in striatum of the freely moving rat: involvement of calcium and high affinity transporter mechanisms. | Del Arco A et al. | β | 1998 | β |
| "Atypical" neuromodulatory profile of glutapyrone, a representative of a novel 'class' of amino acid-containing dipeptide-mimicking 1,4-dihydropyridine (DHP) compounds: in vitro and in vivo studies. | Misane I et al. | β | 1998 | β |
| Biological research on schizophrenia. | Toru M | β | 1998 | β |
| Cocaine-induced activation of striatal neurons during focused stereotypy in rats. | White IM et al. | β | 1998 | β |
| Differences between electrically-, ritalin- and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of Attention-Deficit Hyperactivity Disorder. | Russell V et al. | β | 1998 | β |
| Dizocilpine and reduced body temperature do not prevent methamphetamine-induced neurotoxicity in the vervet monkey: [11C]WIN 35,428 - positron emission tomography studies. | Melega WP et al. | β | 1998 | β |
| Effects of prenatal methylazoxymethanol treatment on striatal dopaminergic systems in rat brain. | Watanabe M et al. | β | 1998 | β |
| Glutamatergic involvement in psychomotor stimulant action. | Rockhold RW | β | 1998 | β |
| Injection of the protein kinase C inhibitor Ro31-8220 into the nucleus accumbens attenuates the acute response to amphetamine: tissue and behavioral studies. | Browman KE et al. | β | 1998 | β |
| Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. | Jones SR et al. | β | 1998 | β |
| Modulation of synaptic transmission by dopamine and norepinephrine in ventral but not dorsal striatum. | Nicola SM et al. | β | 1998 | β |
| Neuroadaptations involved in amphetamine and cocaine addiction. | White FJ et al. | β | 1998 | β |
| Neuroethological assessment of amphetamine-induced behavioral changes and their reversal by neuroleptics: focus on the amygdala and nucleus accumbens. | Wang Z et al. | β | 1998 | β |
| Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy. | Plessinger MA | β | 1998 | β |
| Psychotomimetic-induction of tissue plasminogen activator mRNA in corticostriatal neurons in rat brain. | Hashimoto T et al. | β | 1998 | β |
| Reduced transduction mechanisms in the anterior accumbal interface of an animal model of Attention-Deficit Hyperactivity Disorder. | Papa M et al. | β | 1998 | β |
| Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. | Fumagalli F et al. | β | 1998 | β |
| The effects of nicotine on dopamine and DOPAC output from rat striatal tissue. | Dluzen DE et al. | β | 1998 | β |
| The glutamate hypothesis of schizophrenia. | Akhondzadeh S | β | 1998 | β |
| A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. | Pierce RC et al. | β | 1997 | β |
| Administration of fenfluramine at different ambient temperatures produces different core temperature and 5-HT neurotoxicity profiles. | Malberg JE et al. | β | 1997 | β |
| Amphetamine and fenfluramine suppress ethanol intake in ethanol-dependent rats. | Yu YL et al. | β | 1997 | β |
| Amphetamine increases the phosphorylation of neuromodulin and synapsin I in rat striatal synaptosomes. | Iwata S et al. | β | 1997 | β |
| Amphetamine-induced sensitization and release of dopamine in slices from the ventral tegmental area of rats is enhanced following administration of cholera toxin into the ventral tegmental area. | Byrnes JJ et al. | β | 1997 | β |
| Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine. | Crespi D et al. | β | 1997 | β |
| Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners. | Huether G et al. | β | 1997 | β |
| Dopamine depresses excitatory and inhibitory synaptic transmission by distinct mechanisms in the nucleus accumbens. | Nicola SM et al. | β | 1997 | β |
| Effects of repeated methamphetamine administration on dopamine D1 receptor, D2 receptor and adenylate cyclase type V mRNA levels in the rat striatum. | Shishido T et al. | β | 1997 | β |
| Enhancement of the locomotor response to apomorphine in pertussis toxin-treated animals depends on the site of pertussis toxin injection into the ventral tegmental area. | Narayanan S et al. | β | 1997 | β |
| Ethological and 6-[18F]fluoro-L-DOPA-PET profiles of long-term vulnerability to chronic amphetamine. | Melega WP et al. | β | 1997 | β |
| Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. | Piazza PV et al. | β | 1997 | β |
| Iontophoresis of amphetamine in the neostriatum and nucleus accumbens of awake, unrestrained rats. | Kiyatkin EA et al. | β | 1997 | β |
| Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. | Sonders MS et al. | β | 1997 | β |
| Murine vesicular monoamine transporter 2: molecular cloning and genomic structure. | Takahashi N et al. | β | 1997 | β |
| Quantitative measurements of released amines from individual exocytosis events. | Clark RA et al. | β | 1997 | β |
| Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. | Pierce RC et al. | β | 1997 | β |
| The effect of N-methylation on fenfluramine's neurotoxic and pharmacologic actions. | Fasciano J et al. | β | 1997 | β |
| VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. | Takahashi N et al. | β | 1997 | β |
| Amygdaloid neurons respond to clozapine rather than haloperidol in behaving rats pretreated with intra-amygdaloid amphetamine. | Wang Z et al. | β | 1996 | β |
| Characterization of the sympathetic nerve responses to amphetamine: role of central alpha 2-adrenergic receptors. | Liu W et al. | β | 1996 | β |
| Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP. | Albers DS et al. | β | 1996 | β |
| Effects of D-amphetamine on response acquisition with immediate and delayed reinforcement. | LeSage MG et al. | β | 1996 | β |
| Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. | Piazza PV et al. | β | 1996 | β |
| Individual differences in dopamine release but not rotational behavior correlate with extracellular amphetamine levels in caudate putamen in unlesioned rats. | Clausing P et al. | β | 1996 | β |
| Knockout mice and dirty drugs. Drug addiction. | Uhl GR et al. | β | 1996 | β |
| Modifications of the Brandel Superfusion 600 system and other revisions in superfusion technique improve the measurement of endogenous dopamine release in vitro. | Delle Donne KT et al. | β | 1996 | β |
| The effect of methamphetamine on histamine level and histidine decarboxylase activity in the rat brain. | Ito C et al. | β | 1996 | β |
| The spontaneous release of acetylcholinesterase in rat substantia nigra is altered by local changes in extracellular levels of dopamine. | Dally JJ et al. | β | 1996 | β |
| Effects of sigma receptor ligands on the extracellular concentration of dopamine in the striatum and prefrontal cortex of the rat. | Gudelsky GA | β | 1995 | β |
| Mixed D2/5-HT2A antagonism of amphetamine-induced facilitation of brain stimulation reward. | Frank RA et al. | β | 1995 | β |
| Nitric oxide regulation of methamphetamine-induced dopamine release in caudate/putamen. | Bowyer JF et al. | β | 1995 | β |
| Okadaic acid modulates exocytotic and transporter-dependent release of dopamine in bovine retina in vitro. | Bugnon O et al. | β | 1995 | β |
| Phencyclidine-induced increases in striatal neuron firing in behaving rats: reversal by haloperidol and clozapine. | White IM et al. | β | 1995 | β |
| Aging impairs methamphetamine-induced free-running and anticipatory locomotor activity rhythms in rats. | Shibata S et al. | β | 1994 | β |
| A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. | Rebec GV et al. | β | 1994 | β |
| Bilateral imbalance in striatal DA-uptake controls rotation behavior. | Gordon I et al. | β | 1994 | β |
| Cortical lesions attenuate the opposing effects of amphetamine and haloperidol on neostriatal neurons in freely moving rats. | Tschanz JT et al. | β | 1994 | β |
| Halothane anesthesia enhances the effect of dopamine uptake inhibition on interstitial levels of striatal dopamine. | Fink-Jensen A et al. | β | 1994 | β |
| Psychomotor stimulant effects of d-amphetamine, MDMA and PCP: aggressive and schedule-controlled behavior in mice. | Miczek KA et al. | β | 1994 | β |
| Repeated treatment with ascorbate or haloperidol, but not clozapine, elevates extracellular ascorbate in the neostriatum of freely moving rats. | Pierce RC et al. | β | 1994 | β |
| Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. | Gu H et al. | β | 1994 | β |
| The effect of repeated amphetamine treatment on striatal DA transporter and rotation in rats. | Mintz M et al. | β | 1994 | β |